tavneos
tavneos: developed by 1 company · 1 FDA decision.
tavneos evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect tavneos to CCXI; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could tavneos → CCXI affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Lupus nephritis (LN)
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (1)
| Company | Phase |
|---|---|
| ChemoCentryx, Inc. (CCXI) Lupus nephritis (LN) | Preclinical |
FDA Decisions1 records
Frequently asked questions
Who is developing tavneos?
tavneos is being developed by ChemoCentryx, Inc..
What is tavneos's latest FDA decision?
The most recent tracked FDA decision for tavneos is Approval, dated October 7, 2021.